Amy is a mental health researcher with over 15 years of experience spanning both the not-for-profit and academic sectors. For the past decade, she has been a key part of the Primary Care Mental Health Team in the Department of General Practice and Primary Care (DGPPC), where she has built up expertise in clinical trials, participant recruitment, research ethics, and evaluation. With a background in Psychology, Amy is a mixed-methods researcher and has used realist evaluation and behaviour change theory to deliver meaningful insights that influence how we approach patient-centred mental health care in primary care.
Currently, Amy is leading research and evaluation for a new mental health model of care in general practice, including the implementation of the Link-me prognosis tool for mental health risk. She also plays a central role in WiserAD, Australia’s first antidepressant deprescribing intervention, which helps patients make informed decisions about stopping their medication safely. Amy’s PhD (completed in 2024) was a deeper investigation of the factors that make antidepressant deprescribing successful in primary care. This has shaped her current research interests in further exploring these factors and how they impact or are impacted by the patient-prescriber relationship.
In addition to these projects, Amy is involved in The MiND Study which is testing for a blood biomarker for the diagnosis of neurogenerative disease. She is also an investigator on a project focused on building capacity in GPs and residential aged care staff to better support the mental health needs of older Australians. Amy is also an investigator on the A-Part of the Crowd project, funded by the Medibank Health Foundation, which tackles loneliness and wellbeing among young Australians.